FDA — authorised 10 April 1963
- Status: approved
🇺🇸 Quimethazin in United States
FDA authorised Quimethazin on 10 April 1963
Marketing authorisations
FDA — authorised 10 April 1963
- Application: NDA013264
- Marketing authorisation holder: LEDERLE
- Local brand name: HYDROMOX
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: NDA013927
- Marketing authorisation holder: LEDERLE
- Local brand name: HYDROMOX R
- Indication: TABLET — ORAL
- Status: approved
Quimethazin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Quimethazin approved in United States?
Yes. FDA authorised it on 10 April 1963; FDA authorised it on 10 April 1963; FDA has authorised it.
Who is the marketing authorisation holder for Quimethazin in United States?
Marketing authorisation holder not available in our data.